Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Thomas McCourt is recorded as CEO, CFO and Board Member at Ironwood Pharmaceuticals Inc (IRWD). Ironwood Pharmaceuticals Inc reported in an 8-K filed December 5, 2024 that Thomas McCourt was appointed principal financial officer on an interim basis, effective December 18, 2024. Ironwood Pharmaceuticals Inc reported in an 8-K filed June 22, 2023 that Thomas McCourt was appointed Director, effective June 20, 2023. Thomas McCourt has spoken on 6 earnings calls across 1 company, most recently for Ironwood Pharmaceuticals Inc on February 25, 2026.
“Effective December 18, 2024, Thomas McCourt, the Company's Chief Executive Officer, will serve as the Company's principal financial officer on an interim basis until a new principal financial officer is designated.”
“The stockholders elected nine director nominees, each to serve on the board of directors of the Company for a one-year term extending until the 2024 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, or until his or her death, resignation or removal, based on the following votes:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-12-18–present
2021-06-04–present
Recorded roles and call appearances connecting this person to public companies.
CEO, CFO, Board Member
2021-06-04–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
